sakuranetin has been researched along with Malignant Melanoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Stompor, M | 1 |
| Drira, R; Sakamoto, K | 1 |
1 review(s) available for sakuranetin and Malignant Melanoma
| Article | Year |
|---|---|
A Review on Sources and Pharmacological Aspects of Sakuranetin.
Topics: Anti-Allergic Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antioxidants; Antiparasitic Agents; Antiviral Agents; Cell Proliferation; Colonic Neoplasms; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Flavonoids; Glycosides; Humans; Melanoma; Oryza; Phytoalexins; Phytotherapy; Prunus; Sesquiterpenes; Tumor Cells, Cultured | 2020 |
1 other study(ies) available for sakuranetin and Malignant Melanoma
| Article | Year |
|---|---|
Sakuranetin Induces Melanogenesis in B16BL6 Melanoma Cells through Inhibition of ERK and PI3K/AKT Signaling Pathways.
Topics: Animals; Flavonoids; Melanoma; Mice; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Real-Time Polymerase Chain Reaction; Signal Transduction | 2016 |